Mark Heller serves as chair of the firm’s FDA Group and is a member of the Life Sciences Practice. He focuses on Food and Drug Administration and Federal Trade Commission laws and enforcement counseling and litigation.
PUBLICATIONS AND PRESENTATIONS
Mr. Heller has lectured widely on medical device law and has participated in teaching courses on device regulation. He is the author of Thompson Publishing’s Guide to Medical Device Regulation, and has authored and co-authored chapters in texts on crisis management and the regulation of biomaterials.
PROFESSIONAL EXPERIENCE
Prior to joining Goodwin Procter in 2007, Mr. Heller was chair of the FDA Department at WilmerHale. Before that, he spent almost 10 years in the FDA’s Chief Counsel’s office, where he was actively involved in offensive and defensive litigation, including drug and device cases. During his last six years with the FDA, Mr. Heller was the associate chief counsel for medical devices responsible for the legal aspects of the agency's combination product, device enforcement, premarket notification, investigational device exemption, reclassification and premarket approval programs. He also was involved in the development of the Safe Medical Devices Act of 1990 while on detail to the office of the chairman (Senator Edward M. Kennedy) of the Senate Committee on Labor and Human Resources.
Before joining the FDA, Mr. Heller was with the Federal Trade Commission for eight and a half years. He focused on the regulation of food, drug and device advertising. Mr. Heller has received several awards for excellence for his work at both the FDA and FTC.
BAR AND COURT ADMISSIONS
Mr. Heller is admitted to practice in the District of Columbia.
RECOGNITION
Mr. Heller has been listed in Chambers USA: America’s Leading Lawyers for Business (2006, 2007, 2008 and 2009) and The Best Lawyers in America (2007, 2008, 2009 and 2010). He has been prominently featured as one of three “leading” lawyers in the 2006/2007 and 2008/2009 editions of PLC Cross-border Life Sciences Handbook in the USA Regulatory [medical devices] category. The handbook also bestowed similar recognition upon Goodwin Procter’s FDA Group. Mr. Heller was named a “Leading FDA Lawyer” in 2005 by the Legal Times, which recognized him as an “intellectual powerhouse” and praised his significant knowledge of the law on medical devices and his specialty – “getting the green light from the FDA.” He was recognized by Washingtonian magazine in 2004 and 2007 as one of the top lawyers in Washington, D.C. in the area of food and drugs, and was selected as a “D.C. Super Lawyer” in 2007, 2008 and 2009.